A teen in Florida may be deported if she refuses to get the Gardasil vaccine.
Seventeen-year-old Simone Davis has been applying for citizenship for almost 10 years. When she was 3, she was abandoned and then adopted by her paternal grandmother, who married an American. The family moved to Port St. Joe, Fla.
Now, because she refuses to get the HPV vaccine, she may be sent back to England. That’s because Gardasil is among the required vaccines for citizenship. This vaccine is not mandated for American girls, though different localities have their own laws.
The FDA is recommending Gardasil for boys, saying in a memo that it seems to be safe and effective in preventing genital warts in young men and boys. And guess what! None of the boys tested got cervical cancer! Kidding.
Here in Virginia, health officials are pushing the vaccine that protects against HPV. As the Washington Post reports, the Commonwealth wants Gardasil administered to every girl entering the 6th grade. Parents here can opt out simply by refusing to give their girls the shot.
But fears of adverse affects still abound. This month, a study in the Journal of the American Medical Association showed that in the 2.5 years between June 2006 and December 2008, there were
12,424 reports of side effects, or 54 reports per 100,000 doses given. That included 32 reports of death, or 1 per 1 million girls vaccinated, though it’s unclear whether the vaccine or something else was to blame.
An NPR report also stated that we’re not sure how many of those deaths were due to preexisting conditions in the teen girls, such as blood clots:
All of these people had a known risk factor for having blood clots. Most commonly was that they were on some sort of estrogen birth control. But obesity, traveling, immobility and some of these people had genetic risk factors for getting - for having blood clots, as well.
So…we’re blaming the girls for their deaths? For their previously unknown medical conditions? Not only are we as yet uncertain of Gardasil’s safety, we also have no clue about its efficacy, especially long-term.